Literature DB >> 16480988

The socio-economical impact of paediatric fracture clinic appointments.

M W J Morris1, M J Bell.   

Abstract

The aim of our study was to quantify the indirect cost of a paediatric fracture clinic appointment on society. Our study took place in a paediatric outpatients department using two questionnaires, completed at the time of attendance. The primary measures were days off work and pay lost for the carer and time out from education of the patient. One hundred consecutive patients were asked to complete a after their appointment. Seventy-one were completed. A second clinic evaluation sheet was completed by the surgeons seeing the patients, to assess the appropriateness of the attendance. The results showed that for every 100 appointments 25 working days were lost and 18 people lost pay. Fifty-four days of school were missed as a direct result of attending clinic for review. We showed that 93% of the clinic attendances were thought to be appropriate from the perspective of the surgeon seeing the patient. Streamlining the aftercare of fractures can relieve this considerable socioeconomic burden.

Entities:  

Mesh:

Year:  2006        PMID: 16480988     DOI: 10.1016/j.injury.2005.12.010

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  14 in total

1.  Fifth metatarsal fractures in skeletally immature patients do not need routine orthopedic surgeon assessment and follow-up.

Authors:  Danielle Meschino; John Adamich; Eliane Rioux Trottier; Mark Camp
Journal:  Paediatr Child Health       Date:  2020-12-29       Impact factor: 2.253

2.  N-methyl pyrrolidone promotes ankle fracture healing by inhibiting inflammation via suppression of the mitogen-activated protein kinase signaling pathway.

Authors:  Jun Bian; Dan Cao; Jie Shen; Bo Jiang; Dan Chen; Lanzheng Bian
Journal:  Exp Ther Med       Date:  2018-02-07       Impact factor: 2.447

3.  Validity of parental recall of children's fracture: implications for investigation of childhood osteoporosis.

Authors:  R J Moon; A Lim; M Farmer; A Segaran; N M P Clarke; N C Harvey; C Cooper; J H Davies
Journal:  Osteoporos Int       Date:  2015-08-19       Impact factor: 4.507

4.  A multi-center, randomized, clinical study to compare the effect and safety of autologous cultured osteoblast(Ossron) injection to treat fractures.

Authors:  Seok-Jung Kim; Yong-Woon Shin; Kyu-Hyun Yang; Sang-Bum Kim; Moon-Jib Yoo; Suk-Ku Han; Soo-Ah Im; Yoo-Dong Won; Yerl-Bo Sung; Taek-Soo Jeon; Cheong-Ho Chang; Jae-Deog Jang; Sae-Bom Lee; Hyun-Cho Kim; Soo-Young Lee
Journal:  BMC Musculoskelet Disord       Date:  2009-02-12       Impact factor: 2.362

Review 5.  Pediatric Hand Fracture Referring Practices: A Scoping Review.

Authors:  Rebecca L Hartley; Anna R Todd; Alan R Harrop; Frankie O G Fraulin
Journal:  Plast Surg (Oakv)       Date:  2019-09-24       Impact factor: 0.947

6.  Interventions for treating wrist fractures in children.

Authors:  Helen Hg Handoll; Joanne Elliott; Zipporah Iheozor-Ejiofor; James Hunter; Alexia Karantana
Journal:  Cochrane Database Syst Rev       Date:  2018-12-19

7.  Ethnic and geographic variations in the epidemiology of childhood fractures in the United Kingdom.

Authors:  Rebecca J Moon; Nicholas C Harvey; Elizabeth M Curtis; Frank de Vries; Tjeerd van Staa; Cyrus Cooper
Journal:  Bone       Date:  2016-01-21       Impact factor: 4.398

8.  Epidemiology of paediatric lower extremity fractures in a tertiary care center in Switzerland.

Authors:  Emmélie Chaibi; Pierre-Yves Zambelli; Sophie Merckaert
Journal:  Eur J Trauma Emerg Surg       Date:  2020-05-27       Impact factor: 2.374

9.  Paediatric fracture clinic design--current practice and implications for change.

Authors:  James S Huntley
Journal:  BMC Res Notes       Date:  2014-02-20

10.  One and done? Outcomes from 3961 patients managed via a virtual fracture clinic pathway for paediatric fractures.

Authors:  Jim Kennedy; Carol Blackburn; Michael Barrett; Patrick O'Toole; David Moore
Journal:  J Child Orthop       Date:  2021-06-01       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.